glutamic acid and Cystadenoma, Serous

glutamic acid has been researched along with Cystadenoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aghajanian, C; Berger, MF; Dao, F; Delair, D; Garg, K; Grisham, RN; Hyman, DM; Iasonos, A; Iyer, G; Levine, DA; Solit, DB; Spriggs, DR; Zhou, Q	1

Other Studies

1 other study(ies) available for glutamic acid and Cystadenoma, Serous

Article	Year
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer, 2013, Feb-01, Volume: 119, Issue:3 Topics: Aged; Amino Acid Substitution; Biomarkers, Tumor; Cystadenoma, Serous; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Middle Aged; Mutation, Missense; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins B-raf; Survival Analysis; Valine	2013

Article

Year

BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.

Cancer, 2013, Feb-01, Volume: 119, Issue:3

Topics: Aged; Amino Acid Substitution; Biomarkers, Tumor; Cystadenoma, Serous; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Middle Aged; Mutation, Missense; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins B-raf; Survival Analysis; Valine

2013